News & Updates

Elevations in intraocular pressure (IOP) occur commonly in uveitis patients who are receiving treatment with topical difluprednate, a study has found. This IOP elevation risk is pronounced among children and adult patients with concurrent systemic corticosteroids.

New drug applications approved by US FDA as of 16-31 March 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Linezolid-based chemotherapeutic regimens appear to be useful for treating multidrug-resistant spinal tuberculosis in patients who have undergone spinal surgery, according to a study.

Acute ischaemic stroke (AIS) patients receiving blood pressure (BP)-lowering treatment with renin-angiotensin system (RAS) inhibitors before the index event exhibit less severe stroke and develop intracranial haemorrhage less frequently compared with those on non-RAS inhibitors prior to stroke, according to a study.

While the mRNA vaccines currently available on the market have gained regulatory nods* for use in children aged 5 or 6 years old**, Moderna’s mRNA-1273 vaccine is setting a “new low” by showing that two 25 μg doses of the vaccine induce a robust immune response in infants/children as young as 6 months to <6 years of age, according to the latest data from the KidCOVE study.